The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Design and development of the molecular analysis for Therapy Choice (NCI-MATCH) Designated Laboratory Network.
 
James V. Tricoli
No Relationships to Disclose
 
Linda Zane
No Relationships to Disclose
 
Robin Harrington
Stock and Other Ownership Interests - Gilead Sciences
 
Laura Yee
No Relationships to Disclose
 
Kneshay N. Harper
No Relationships to Disclose
 
Ting-Chia Chang
No Relationships to Disclose
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
 
Alice P. Chen
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Apricity Health; Checkmate Pharmaceuticals; Clovis Oncology; FOGPharma; Fount Therapeutics; Loxo; Oncoceutics; PIC Therapeutics; Shattuck Labs; Strata Oncology; Tvardi Therapeutics; Vivid Biosciences; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Array BioPharma; Asana Biosciences; Boston Biomedical; Bristol-Myers Squibb; Cell Medica; Debiopharm Group; FOGPharma; Genentech; Incyte; Lilly; Loxo; Merck; Neon Therapeutics; Novartis; Oncoceutics; Pierre Fabre; Roche; Sanofi; Shattuck Labs; Takeda; Tolero Pharmaceuticals; Tvardi Therapeutics; Verastem
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - Debiopharm Group; Pierre Fabre
 
Peter J. O'Dwyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Amgen; Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics
 
Barbara A. Conley
No Relationships to Disclose
 
Cynthia Winter
No Relationships to Disclose
 
Jennifer Lee
No Relationships to Disclose
 
Paul M. Williams
Research Funding - Illumina (Inst)
Patents, Royalties, Other Intellectual Property - I was a co-inventor of the DLBCL cell of origin patent recently filed by the NIH
 
Jeffrey Sklar
Research Funding - Jilin Zixin
 
David Patton
No Relationships to Disclose
 
Gregory J. Tsongalis
Honoraria - AccuGenomics; ChromaCode; Seracare; Theranos
Consulting or Advisory Role - AstraZeneca; Seracare
Research Funding - Agena Bioscience; Archer; Biocartis; Illumina; Pillar Biosciences; QuantuMDx
 
Stanley R. Hamilton
Consulting or Advisory Role - Bristol-Myers Squibb; Guardant Health; HalioDx; Loxo; Merck; Thermo Fisher Scientific
 
A. John Iafrate
Stock and Other Ownership Interests - Archer
Consulting or Advisory Role - Chugai Pharma; Debiopharm Group; Roche
Research Funding - Blueprint Medicines
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Chris Alan Karlovich
Stock and Other Ownership Interests - Clovis Oncology
Research Funding - Illumina (Inst)